Clinical observation of pnehyclidine hydrochloride as postoperative medication on oral and maxillofacial surgery patients

SUN Yu,FANG Shu-dong,KANG Hua,ZHU Ye-sen
DOI: https://doi.org/10.3969/j.issn.1672-3244.2007.04.008
2007-01-01
Abstract:PURPOSE:To evaluate the effects of pnehyclidine hydrochloride as postoperative medication on patients of oral and maxillofacial surgery.METHODS:45 ASA(American Society of Anesthesiologists) Ⅰ-Ⅱ patients undergoing oral and maxillofacial surgery were randomly divided into 3 groups(A,B and C) who received normal saline,atropine(0.5mg) or pnehyclidine hydrochloride(0.01mg/kg) for intramuscular injection as postoperative medication respectively.The first medication was at the end of the operation and the second was 24 hours later.During the postoperative period,we observed the average salivary gland and airway secretion per hour in 0-12 hours,12-24 hours,24-36 hours and 36-48 hours.The adverse effects were also recorded.SAS6.12 software package was used for comparison of the differences between each group.RESULTS:During the first 12 hours after medication(0-12 hours and 24-36 hours) ,the salivary gland secretion per hour was significantly decreased in group B and C compared with group A(P0.05 and P0.01) .There was significant difference between group B and C(P0.05) .During the second 12 hours(12-24 hours and 36-48 hours) ,the salivary gland secretion per hour was significantly decreased in group C compared with group A(P0.05) .The airway secretion per hour was significantly decreased in group C compared with group A and B(P0.05) .No serious adverse event was noted.CONCLUSION:Postoperative medication with pnehyclidine hydrochloride can effectively and safely decrease the secretion of salivary gland and airway on patients of oral and maxillofacial surgery.
What problem does this paper attempt to address?